Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 5/2008

01-05-2008 | Focus on

Advances in prostate cancer imaging techniques and strategies

Author: Giovanni Lucignani

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2008

Login to get access

Excerpt

In a review paper on the epidemiology of prostate cancer published a few years back, Henrik Grönberg, from the Department of Radiation Sciences/Oncology at Umeå University, Sweden, states that prostate cancer is the sixth most common cancer in the world (in terms of the number of new cases), the third most common cancer in men, and the most common cancer in men in Europe, North America, and some parts of Africa. In 2000, the number of new cases of prostate cancer was estimated at 513,000 worldwide, and this disease accounts for 97% of all cancers in men (153% in developed countries and 43% in developing countries). The incidence of prostate cancer is increasing steadily in almost all countries, yet we know little about its causes [1]. …
Literature
3.
4.
go back to reference Pallwein L, Mitterberger M, Pelzer A, Bartsch G, Strasser H, Pinggera GM, et al. Ultrasound of prostate cancer: recent advances. Eur Radiol. 2007 Oct 16 [Epub ahead of print]. DOI 10.1007/s00330-007-0779-7. Pallwein L, Mitterberger M, Pelzer A, Bartsch G, Strasser H, Pinggera GM, et al. Ultrasound of prostate cancer: recent advances. Eur Radiol. 2007 Oct 16 [Epub ahead of print]. DOI 10.​1007/​s00330-007-0779-7.
5.
go back to reference Zalesky M, Urban M, Smerhovský Z, Zachoval R, Lukes M, Heracek J. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer. Int J Urol. 2008;15(1):68-75. Jan.CrossRefPubMed Zalesky M, Urban M, Smerhovský Z, Zachoval R, Lukes M, Heracek J. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer. Int J Urol. 2008;15(1):68-75. Jan.CrossRefPubMed
6.
go back to reference Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007;70(6):1136-40. Dec.CrossRefPubMed Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007;70(6):1136-40. Dec.CrossRefPubMed
7.
go back to reference Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008;18(1):71-7. Jan.CrossRefPubMedPubMedCentral Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008;18(1):71-7. Jan.CrossRefPubMedPubMedCentral
8.
go back to reference Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008;246(1):177-84. Jan.CrossRefPubMed Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology. 2008;246(1):177-84. Jan.CrossRefPubMed
9.
go back to reference Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3 T using a phased-array coil: preliminary results. Invest Radiol. 2007;42(12):842-7. Dec.CrossRefPubMed Kim CK, Park BK, Lee HM, Kwon GY. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3 T using a phased-array coil: preliminary results. Invest Radiol. 2007;42(12):842-7. Dec.CrossRefPubMed
10.
go back to reference Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology. 2008;246(1):168-76. Jan.CrossRefPubMed Wang L, Mazaheri Y, Zhang J, Ishill NM, Kuroiwa K, Hricak H. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Radiology. 2008;246(1):168-76. Jan.CrossRefPubMed
11.
go back to reference Bouchelouche K, Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol. 2008;179(1):34-45. Jan.CrossRefPubMed Bouchelouche K, Oehr P. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review. J Urol. 2008;179(1):34-45. Jan.CrossRefPubMed
12.
go back to reference Takahashi N, Inoue T, Lee J, Yamaguchi T, Shizukuishi K. The roles of PET and PET/CT in the diagnosis and management of prostate cancer. Oncology. 2007;72(3-4):226-33.CrossRefPubMed Takahashi N, Inoue T, Lee J, Yamaguchi T, Shizukuishi K. The roles of PET and PET/CT in the diagnosis and management of prostate cancer. Oncology. 2007;72(3-4):226-33.CrossRefPubMed
13.
go back to reference Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi V, Cozzarini C, et al. [11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging. 2008 Jan 16; [Epub ahead of print]. DOI 10.1007/s00259-008-0716-2. Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi V, Cozzarini C, et al. [11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging. 2008 Jan 16; [Epub ahead of print]. DOI 10.​1007/​s00259-008-0716-2.
14.
go back to reference Eschmann SM, Pfannenberg AC, Rieger A, Aschoff P, Müller M, Paulsen F, et al. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin. 2007;46(5):161-8.PubMed Eschmann SM, Pfannenberg AC, Rieger A, Aschoff P, Müller M, Paulsen F, et al. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer. Nuklearmedizin. 2007;46(5):161-8.PubMed
15.
go back to reference Vavere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-Acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008 Jan 16; [Epub ahead of print]. DOI 10.2967/jnumed.107.046672. Vavere AL, Kridel SJ, Wheeler FB, Lewis JS. 1-11C-Acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008 Jan 16; [Epub ahead of print]. DOI 10.​2967/​jnumed.​107.​046672.
16.
17.
go back to reference Manikandan R, Qazi HA, Philip J, Mistry R, Lamb GH, Woolfenden KA, et al. Routine use of magnetic resonance imaging in the management of T(1c) carcinoma of the prostate: is it necessary. J Endourol. 2007;21(10):1171-4. Oct.CrossRefPubMed Manikandan R, Qazi HA, Philip J, Mistry R, Lamb GH, Woolfenden KA, et al. Routine use of magnetic resonance imaging in the management of T(1c) carcinoma of the prostate: is it necessary. J Endourol. 2007;21(10):1171-4. Oct.CrossRefPubMed
18.
go back to reference Shukla-Dave A, Hricak H, Scardino PT. Imaging low-risk prostate cancer. Curr Opin Urol. 2008;18(1):78-86. Jan.CrossRefPubMed Shukla-Dave A, Hricak H, Scardino PT. Imaging low-risk prostate cancer. Curr Opin Urol. 2008;18(1):78-86. Jan.CrossRefPubMed
19.
go back to reference Fuchsjäger M, Shukla-Dave A, Akin O, Barentsz J, Hricak H. Prostate cancer imaging. Acta Radiol. 2008;49(1):107-20. Feb.CrossRefPubMed Fuchsjäger M, Shukla-Dave A, Akin O, Barentsz J, Hricak H. Prostate cancer imaging. Acta Radiol. 2008;49(1):107-20. Feb.CrossRefPubMed
20.
go back to reference Larson SM, Schöder H. Advances in positron emission tomography applications for urologic cancers. Curr Opin Urol. 2008;18(1):65-70. Jan.CrossRefPubMed Larson SM, Schöder H. Advances in positron emission tomography applications for urologic cancers. Curr Opin Urol. 2008;18(1):65-70. Jan.CrossRefPubMed
Metadata
Title
Advances in prostate cancer imaging techniques and strategies
Author
Giovanni Lucignani
Publication date
01-05-2008
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0784-3

Other articles of this Issue 5/2008

European Journal of Nuclear Medicine and Molecular Imaging 5/2008 Go to the issue